Mr. Speaker, yesterday, the Government of Quebec unveiled its new biopharmaceutical strategy. It includes an initiative along the lines of the Bloc Québécois' economic recovery plan, which proposes to allow businesses to claim on a quarterly basis tax credits for research and development.
What is the government waiting for to act on this proposal from the Bloc Québécois that would ensure that all businesses can have access to cash and reinvest it immediately in their development activities?